Title : Intestinal MYC modulates obesity-related metabolic dysfunction.

Pub. Date : 2021 Jul

PMID : 34211180






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Finally, we show that administration of the MYC inhibitor 10058-F4 has beneficial effects on high-fat-diet-induced metabolic disorders, and is accompanied by increased GLP-1 and reduced ceramide levels in serum. 5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one myelocytomatosis oncogene Mus musculus